22 related articles for article (PubMed ID: 21488210)
1. Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.
Li Y; Zhao J; Hölscher C
CNS Drugs; 2017 Aug; 31(8):639-652. PubMed ID: 28634902
[TBL] [Abstract][Full Text] [Related]
2. [Neuroprotective effects of paeonol in a cell model of Parkinson disease].
Wang H; Geng ZM; Hu ZW; Wang SY; Zhao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 44(1):30-6. PubMed ID: 25851972
[TBL] [Abstract][Full Text] [Related]
3. [Zileuton, a 5-lipoxygenase inhibitor, attenuates mouse microglial cell-mediated rotenone toxicity in PC12 cells].
Zhang XY; Chen L; Xu DM; Wang XR; Wang YF; Li CT; Wei EQ; Zhang LH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):273-80. PubMed ID: 24998649
[TBL] [Abstract][Full Text] [Related]
4. Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells.
Li CT; Zhang WP; Lu YB; Fang SH; Yuan YM; Qi LL; Zhang LH; Huang XJ; Zhang L; Chen Z; Wei EQ
J Neurosci Res; 2009 Mar; 87(4):991-1001. PubMed ID: 18951527
[TBL] [Abstract][Full Text] [Related]
5. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
[TBL] [Abstract][Full Text] [Related]
6. 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma.
Xu XM; Deng JJ; Yuan GJ; Yang F; Guo HT; Xiang M; Ge W; Wu YG
Mol Med Rep; 2011; 4(6):1195-200. PubMed ID: 21833474
[TBL] [Abstract][Full Text] [Related]
7. [Expression of 5-lipoxygenase in hippocampal CA1 neuronal damage following global cerebral ischemia in rats].
Chen W; Li C; Zhao J; Zhang X; Han H; Wei E; Zhang L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 42(1):61-6. PubMed ID: 23505109
[TBL] [Abstract][Full Text] [Related]
8. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
[TBL] [Abstract][Full Text] [Related]
9. [5-lipoxygenase inhibitors in asthma therapy].
Tanaka R
Nihon Rinsho; 1996 Nov; 54(11):3040-4. PubMed ID: 8950951
[TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.
Sinha S; Doble M; Manju SL
Bioorg Med Chem; 2019 Sep; 27(17):3745-3759. PubMed ID: 31331653
[TBL] [Abstract][Full Text] [Related]
11. [5-lipoxygenase is involved in rotenone-induced injury in PC12 cells].
Zhang XY; Zhang LH; Li CT; Chen WJ; Zhao JB; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 40(2):150-5. PubMed ID: 21488210
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]